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Nucleotide excision repair (NER) is the main DNA repair pathway in mammals for removal of UV-induced
lesions. NER involves the concerted action of more than 25 polypeptides in a coordinated fashion. The
xeroderma pigmentosum group A protein (XPA) has been suggested to function as a central organizer and
damage verifier in NER. How XPA reaches DNA lesions and how the protein is distributed in time and space
in living cells are unknown. Here we studied XPA in vivo by using a cell line stably expressing physiological
levels of functional XPA fused to green fluorescent protein and by applying quantitative fluorescence micros-
copy. The majority of XPA moves rapidly through the nucleoplasm with a diffusion rate different from those
of other NER factors tested, arguing against a preassembled XPA-containing NER complex. DNA damage
induced a transient (5-min) immobilization of maximally 30% of XPA. Immobilization depends on XPC,
indicating that XPA is not the initial lesion recognition protein in vivo. Moreover, loading of replication protein
A on NER lesions was not dependent on XPA. Thus, XPA participates in NER by incorporation of free diffusing
molecules in XPC-dependent NER-DNA complexes. This study supports a model for a rapid consecutive
assembly of free NER factors, and a relatively slow simultaneous disassembly, after repair.
DNA-damaging agents continuously challenge the integrity
of DNA. DNA lesions directly affect transcription and repli-
cation, leading to cell death and contributing to aging, and also
induce mutations that eventually cause carcinogenesis (13).
Various repair mechanisms have evolved to prevent the con-
sequences of DNA injuries and to preserve genetic integrity
(21, 27). In mammals, the nucleotide excision repair (NER)
process is the most important repair pathway for removal of
UV light-induced lesions, including cyclobutane pyrimidine
dimers (CPDs) and 6-4 photoproducts and a wide range of
helix-distorting chemical adducts. The significance of a func-
tional NER system is apparent from the severe clinical features
expressed by individuals suffering from the hereditary disorder
xeroderma pigmentosum (XP), Cockayne syndrome (CS), and
trichothiodystrophy (TTD) (7). Patients suffering from the
prototype repair disorder XP are extremely sensitive to solar
(UV) exposure, have an increased risk for skin cancer, and
frequently exhibit neurological symptoms.
Detailed biochemical studies have shown that 25 polypep-
tides are required for in vitro NER (4, 15, 38). Two distinct
NER subpathways operate within mammals, transcription-cou-
pled repair (TCR) and global genome repair (GGR), each
addressing a specific genome compartment and category of
damages (10, 25). The distinction between these subpathways
originates from the first steps of the mechanism, i.e., lesion
detection. Lesions that block RNA polymerase II transcription
elongation are preferentially repaired by TCR and require the
CSA, CSB, and XAB2 proteins (45). TCR allows rapid re-
sumption of the vital process of RNA synthesis and is partic-
ularly important for lesions that are inefficiently repaired by
GGR-NER (such as CPDs). Injuries anywhere in the genome
are targeted by the slower operating GGR. Damage sensing in
this process is performed by the XPC/hHR23B/centrin 2 het-
erotrimeric complex (2, 52, 53, 60). In addition, the DNA
damage binding (UV-DDB) protein complex (9, 33) helps to
identify CPDs in GGR (31, 35, 53, 56). On the other hand, a
complex consisting of XPA and the single-stranded DNA bind-
ing protein RPA (replication protein A) (37) has been sug-
gested to be the primary lesion detector in GGR (61), but this
finding was recently challenged by Reardon and Sancar, who
claimed that only RPA is the initial damage sensor (48).
The next step in NER is performed by the nine-subunit
TFIIH complex (60, 64), containing the XPB and XPD heli-
cases. TFIIH locally opens the DNA double helix around the
lesion (20, 22), likely in the presence of XPG. Subsequently,
XPA and RPA play an essential but as yet not fully understood
role in the core of the reaction. XPA and RPA are necessary
for further assembly and proper orientation of the incision
proteins ERCC1/XPF and XPG (14). The latter are structure-
specific endonucleases incising the damaged strand around the
lesion (5 and 3, respectively), leaving an excised stretch of
30 nucleotides. DNA polymerase /ε and auxiliary factors fill
the remaining gap, which is sealed by ligase 1 (15, 27, 38).
Despite detailed knowledge of the in vitro NER mechanism,
little is known about how this process operates in living cells.
Different models for the organization of NER have been pro-
posed, ranging from an ordered assembly of factors (1, 38, 44,
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60) or four defined subcomplexes (23, 48, 61) to a preas-
sembled NER holocomplex (54). Recently, our group provided
evidence that some of the NER constituents roam through the
nucleoplasm by diffusion and are transiently bound to com-
plexes actively engaged in NER (28, 29). The XPA protein
plays a crucial role within NER, since in the absence of this
protein NER is completely abolished. Multiple interactions of
XPA with other NER factors have been reported, suggesting a
central role in complex assembly (14). These include the XPA/
RPA complex exhibiting a higher specificity and affinity for
damaged DNA than XPA alone and the ERCC1/XPF/XPA
ternary complex, as well as an association with TFIIH (sum-
marized in references 5 and 15). In addition, a link between
XPA and TCR was suggested by the observed associations of
CSB with the core NER factors XPA, XPG, and TFIIH (32,
51) and between XPA and XAB2 (45).
To provide further insight into the molecular interactions of
XPA in living cells, we tagged this central NER factor with the
green fluorescent protein (GFP) and studied its distribution
and mobility in living cells. We applied fluorescence-based
imaging and bleaching (fluorescence redistribution after pho-
tobleaching [FRAP]) methods using confocal laser scanning
microscopy (29, 30) in cells containing local UV damage (43,
60). In similar previous studies of the NER factors ERCC1 and
TFIIH (28, 29), our group provided evidence that at least these
proteins do not reside in large NER holocomplexes. Here we
present our findings on the dynamic properties of XPA-GFP,
NER reaction kinetics, and the mode of complex assembly in
living cells.
MATERIALS AND METHODS
Cell lines. Cell lines used in this study were the simian virus 40 (SV40)-
immortalized fibroblasts MRC5 (wild type), XP2OS (XP-A), XP12RO (XP-A),
and XP20MA (XP-C). These were cultured in RPMI-HEPES medium supple-
mented with antibiotics and 10% fetal calf serum at 37°C in an atmosphere of 5%
CO2. Primary fibroblasts used for microneedle injection, C5RO (wild type) and
XP25RO (XP-A), and those used for immunofluorescence studies, VH25 (wild
type), XP25RO (XP-A), XP21RO (XP-C), XPCS1RO (XP-G/CS), XP1DU
(XP-D), XP8BR (XP-D/CS), and XP131MA (XP-B/CS), were cultured in Ham’s
F10 medium supplemented with antibiotics and 15% fetal calf serum.
Generation of GFP-tagged XPA. GFP-tagged XPA was generated by in-frame
ligation of an XPA cDNA fragment (nucleotides 9 to 863) encoding the entire
XPA, except for the first three amino acids, into pEGFP-C1 (Clontech). His9 and
hemagglutinin (HA) tags were both added to the N terminus of enhanced GFP
(eGFP). The His9-HA encoding sequence was introduced via ligation of a dou-
ble-stranded oligonucleotide at the N terminus of eGFP after NheI-NcoI diges-
tion (5 CTAGCAAC ATG GGC CAC CAC CAT CAC CAT CAT CAC CAC
CAC GGC TAC CCA TAC GAT GTT CCA GAT TAC GCA AGC GC 3),
resulting in a fusion gene under the control of a cytomegalovirus promoter
encoding a 9-histidine stretch (underlined)-HA tag (bold)-eGFP–XPA hybrid
polypeptide.
Microneedle injection and UDS. Microinjection of cDNA into cultured,
multinucleated primary XP-A (XP25RO) fibroblasts was performed as described
previously (59). After injection, cells were incubated for 24 h at 37°C in standard
medium to allow expression of the cDNA. Fluorescent (GFP) images were
obtained with an Olympus IX70 microscope (excitation at 455 to 490 nm band
pass filter, long pass emission filter, 510 nm). DNA repair capacity was deter-
mined by measuring unscheduled DNA synthesis (UDS). Fibroblasts were UV
irradiated at 16 J/m2 (254 nm), pulse-labeled for 2 h using [3H]thymidine (20
Ci/ml), and fixed for in situ autoradiography. Autoradiographic grains above
the nuclei of injected polykaryons were counted and compared with the amount
of grains above the nuclei of wild-type primary fibroblasts (C5RO) treated in
parallel.
Transfection of human fibroblasts. XPA- and XPC-deficient human SV40-
transformed fibroblasts were transfected with the His9-HA-eGFP–XPA fusion
expression plasmid containing the NEO gene by using SuperFect (Qiagen). Cells
were diluted 24 h after transfection, and medium containing 0.3 mg of G418
(gentamicin)/ml was added. Gentamicin-resistant XP-A cells were subsequently
selected for UV resistance by irradiation three times (with a 1-day interval) with
4 J of UV-C/m2. Surviving clones were further selected for the presence and
proper expression level of nuclear fluorescence by cell sorting using a FACS-
Vantage cell sorter (Becton Dickinson). eGFP fluorescence was excited at 488
nm with a 20-mW Ar laser, and eGFP emission was detected using a 525-nm
dichroic shortpass mirror and a 530/30-nm bandpass filter.
Immunoblot analysis and UV survival. Whole-cell extracts prepared by soni-
cation were separated by sodium dodecyl sulfate–11% polyacrylamide gel elec-
trophoresis and transferred to nitrocellulose membranes. Expression of the fu-
sion gene was analyzed by hybridizing the membranes with a polyclonal anti-
XPA antibody (Santa Cruz), followed by a secondary antibody (goat anti-rabbit
conjugated with horseradish peroxidase [Biosource International]), and detected
using enhanced chemiluminescence (Amersham).
For UV survival experiments, cells were plated and exposed to different UV
doses 2 days after plating. Survival was determined 3 days after UV irradiation by
incubation at 37°C with [3H]thymidine pulse-labeling as described elsewhere (24).
Immunofluorescence. Cells were grown on glass coverslips and fixed with 2%
paraformaldehyde at 37°C. Coverslips were washed three times for 5 min with
phosphate-buffered saline (PBS) containing 0.1% Triton X-100 and subsequently
washed with PBS (PBS containing 0.15% glycine and 0.5% bovine serum
albumin). Cells were incubated at room temperature with primary antibody for
1.5 h in a moist chamber. Subsequently, coverslips were washed three times with
PBS–Triton X-100 and PBS, incubated for 1 h with secondary antibody at room
temperature, and again washed three times in PBS–Triton X-100. Samples were
embedded in Vectashield mounting medium (Vector) containing 0.1 mg of
DAPI (4-6-diamidino-2-phenylindole)/ml. Primary antibodies used for immu-
nolabeling were as follows: rabbit polyclonal anti-XPA antibodies (kindly pro-
vided by K. Tanaka, Osaka University, Osaka, Japan), rabbit polyclonal anti-
XPC (57), mouse anti-CPD monoclonal antibodies (gift from O. Nikaido,
Kanazawa University, Kanazawa, Japan), and mouse monoclonal anti-RPA70.
Secondary antibodies were as follows: Alexa 594-conjugated goat anti-rabbit
antiserum (Molecular Probes) and Cy2- and Cy3-conjugated goat anti-mouse
antiserum (Jackson ImmunoResearch Laboratories). Fluorescent microscopy
images were obtained with a Leitz Aristoplan microscope equipped with epiflu-
orescence optics and a PLANAPO 63, 1.40-numerical aperture oil immersion
lens or with a Zeiss Axioplan 2 microscope equipped with epifluorescence optics.
Quantification of fluorescence signal was determined using macrocontrolled
digital image analysis software (KS-400; Zeiss).
Confocal microscopy. Digital images of GFP-expressing living cells were ob-
tained using a Zeiss LSM 410 microscope equipped with a 60-mW Ar laser (488
nm) and a 40, 1.3-numerical aperture oil immersion lens. Images of single
nuclei were taken at a sample interval of 100 nm. For analysis of GFP-XPA
expression levels, confocal planes were scanned at relatively low resolution
(625-nm sample interval). A computer-controlled acousto-optic transmission
filter was used to vary the intensity of the line of an Ar laser. GFP fluorescence
was detected using a dichroic beamsplitter (488/543 nm) and an additional 515-
to 540-nm bandpass emission filter.
UV irradiation. For total UV DNA damage induction, cultured cells were
rinsed with PBS and UV irradiated on coverslips with a Philips TUV lamp (254
nm) at a dose rate of 0.8 J/m2/s. To apply local UV damage on living fibro-
blasts, cells were UV irradiated through an isopore polycarbonate filter (Milli-
pore) containing 5-m-diameter pores as described previously (43, 60). Subse-
quently, after filter removal, cells were either cultured or microscopically
examined or fixed with paraformaldehyde and further processed for immunocy-
tochemistry as described above.
FRAP and fluorescence loss in photobleaching (FLIP). FRAP experiments
were used to determine the effective diffusion coefficient (Deff) of GFP-labeled
XPA (under various experimental conditions) (29, 30). Briefly, a narrow strip
spanning the entire nucleus was bleached for 200 ms at high laser intensity (100%
of the 488-nm line of a 60-mW Ar laser). Subsequently, the recovery of fluores-
cence in the strip was monitored at intervals of 100 ms at 5% of the laser intensity
applied for bleaching. The effective diffusion coefficient (Deff) was estimated by
calculating the relative fluorescence intensities given by the equation FRt  (It 	
I0)/(I
 	 I0), where I
 is the fluorescence intensity measured after complete
recovery, I0 is the fluorescence intensity immediately after bleaching, and It is the
fluorescence intensity measured at different time points (at 100-ms intervals).
The resulting curves were fit to a theoretical diffusion model as described pre-
viously (18) (1-D diffusion). In this model, fluorescence recovery (FT) is defined
by the equation FTt  1 	 [w2  (w2  4Dt)	1] , where w is the width of the
1⁄2
bleached strip, D is the diffusion coefficient, and t is time. The optimal fit was
found by minimizing ¥(FRt 	 FTt)2 (ordinary least squares) for both the diffu-
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sion coefficient (D) and the fluorescence intensity immediately after bleaching
(I0). The immobile fraction (FR) was calculated from the equation FR  1 	
[(I
 	 I0)/(It0 	 I0)] 	 (Nmobile,bleached/Ntot), where N represents the number
of molecules, It0 and I0 are the fluorescence intensities immediately before and
after bleaching, respectively, and I
 is the fluorescence intensity measured after
complete recovery. Nmobile,bleached/Ntot is subtracted to correct for the fraction of
mobile molecules in the relatively small volume of the nucleus that were
bleached by the high-intensity laser pulse.
The immobilization measurements of GFP-labeled molecules were performed
using a modified FRAP assay (FRAP-FIM [FRAP for immobilization measure-
ments]) as described previously (29, 30). Using this method, quantitative fluo-
rescence over a confocal plane of the entire nucleus was measured. Briefly, a
small spot in the center of the nucleus was bleached at low laser intensity for a
relatively long period (4 s at relatively low laser intensity [15% of a 60-mW Ar
laser]) with the aim of bleaching a significant proportion of the GFP-tagged
molecules in the nucleus. Subsequently, after an additional 4 s, a postbleach
image was made and compared with a prebleach image of the same focal plane.
The fluorescence intensity ratio (Ipost/Ibleach) was plotted as a function of dis-
tance to the laser bleach spot, generating a fluorescence ratio profile (FRP) (see
Fig. 4). Chemically immobilized molecules (paraformaldehyde fixation) were
used as 100% immobilization controls.
FLIP experiments were used to determine the residence time of GFP-tagged
XPA molecules in local UV-irradiated areas (see above). For this, a strip at a
relatively long distance from the site of local damage was photobleached for 4 s
at relatively low laser intensity. Subsequently, fluorescence intensity was moni-
tored in the local damage area, in the bleached area, and in an undamaged
control region located at the same distance from the bleached area as the local
damage area. The difference between the fluorescence in the damage area and
that in the control region was plotted and the time at which 10% of the initial
difference was reached was taken as an estimate for the residence time of
individual molecules associated with the local damage area.
RESULTS
Construction and characterization of GFP-XPA. The XPA
cDNA was fused to the eGFP cDNA containing histidine and
HA tags at its N terminus (see Materials and Methods), re-
sulting in a His9-HA-eGFP–XPA hybrid gene (designated
GFP-XPA) (Fig. 1A). To verify that the GFP tag did not
interfere with the XPA function, the fusion gene was microin-
jected into nuclei of XPA-deficient human fibroblasts. One day
after microinjection a bright fluorescent signal within the nu-
clei of injected cells was observed (Fig. 1B). Fluorescent cells
were recorded and assayed for their repair capacity by deter-
mining UV-induced UDS. As shown in Fig. 1C, the cells with
green fluorescent nuclei (Fig. 1B) were also corrected (up to
wild-type levels) for the severe UDS defect present in XP-A
cells (noninjected neighboring cells). Both nuclear targeting
and the complete restoration of UDS indicate that the His9-
HA-eGFP tag does not interfere with the proper function of
XPA when transiently expressed in XP-A cells.
Generation and characterization of cells expressing GFP-
XPA. To investigate the in vivo distribution of GFP-XPA in
time and space, the fusion gene was stably expressed in an
XPA-deficient human SV40-immortalized fibroblast. We iso-
lated several UV-resistant clones and analyzed the expression
levels of the fusion proteins by immunoblotting (data not
FIG. 1. Functionality of GFP-XPA. (A) Schematic representation of the His9-HA-eGFP–XPA fusion gene with the different binding domains
indicated. NLS, nuclear localization signal; BD, binding domain; aa, amino acids. (B) Fluorescence image of XP-A cells injected with GFP-tagged
XPA cDNA. Only the multinucleated cell microinjected with GFP-XPA cDNA showed a homogeneous nuclear expression (number 1); surround-
ing cells were not injected (number 2). (C) Measurement of the repair capacity of cells with fluorescent nuclei by means of UV-induced UDS (see
Materials and Methods). The amount of silver grains above the nuclei of the injected cells (number 1) was comparable to what was seen with
wild-type cells (not shown), whereas the surrounding XP-A fibroblasts (number 2) show the low level of DNA synthesis typical for UV-exposed
XP-A cells. The cell indicated with the number 3 is in S phase.
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shown). We selected a clone (clone 40) that expressed the
fusion protein to near normal levels compared with XPA ex-
pression in wild-type cells (Fig. 2). As observed previously,
wild-type XPA migrates as two distinct bands in polyacryl-
amide gel electrophoresis (40 and 42 kDa) (17, 42, 49); the
fusion protein is also present in two forms, migrating at the
expected positions of 68 and 70 kDa. Immunostaining with
anti-GFP (data not shown) revealed that there was no detect-
able free GFP present in the crude extracts. UV survival ex-
periments demonstrated that tagged XPA restores the extreme
UV-sensitive phenotype of XP-A cells to the wild-type range
(Fig. 2B). This confirms the UDS results of the microinjection
at physiological protein levels in stably expressing transfor-
mants.
GFP-XPA appeared to be homogeneously distributed in
living nuclei (Fig. 2C and D), including the nucleoli. In ap-
proximately 40% of the cells, a few (1 to 5) bright fluorescent
spots were observed. GFP signal in fixed cells (Fig. 2E) and
immunofluorescence (anti-XPA) (Fig. 2F) displayed a similar
distribution as in living cells (Fig. 2D), except that nucleoli
seemed devoid of XPA after immunofluorescence (Fig. 2F),
similar to what has been reported previously (42). The lack of
nucleolar staining by immunofluorescence might be caused by
the fixation procedure which renders this highly condensed
organelle less permeable for antibodies (63). Although UV-C
irradiation slightly reduced the number of cells containing
spots, the overall distribution pattern did not change (data not
shown). At present, the nature and significance of these foci re-
main unknown. Similar structures have been found in ERCC1-
GFP-expressing cells (29).
Diffusion of GFP-tagged XPA. Prior to mobility studies of
GFP-XPA in living cells, we first analyzed the expression level
of individual cells in clone 40. Immunofluorescence with anti-
XPA serum was performed on a (1:1) mixed population of
wild-type (MRC5) and clone 40 cells. The frequency distribu-
tion (Fig. 2G) shows that both the level of expression and the
intercellular variation are comparable, with the exception of a
small fraction of cells overexpressing GFP-XPA. Only cells
(from clone 40) with a modal expression level equivalent to
that of wild-type cells were used in further quantitative fluo-
rescent experiments, unless stated otherwise.
Mobility measurements to determine whether GFP-XPA
molecules are mobile or bound to nuclear structures were
performed by applying FRAP. Here we used the strip-FRAP
method (see Materials and Methods and reference 30 for de-
tailed information) to measure the mobility. Briefly, GFP-XPA
molecules were photobleached in a defined narrow strip span-
ning the nucleus (strip-FRAP). The speed of recovery is a
measure for the diffusion rate of the molecules, and the degree
of fluorescence recovery indicates whether (part of) the GFP-
XPA molecules are mobile. For chemically fixed cells, no re-
FIG. 2. Expression and characterization of XP2OS cells stably ex-
pressing GFP-tagged XPA. (A) Immunoblot of 30 g of whole-cell
extract from MRC5 (wild-type) (lane 1), GFP-XPA-transfected
XP2OS (clone 40) (lane 2), and XP2OS (XP-A) (lane 3) cells probed
with polyclonal anti-XPA. The molecular masses of protein markers
are indicated in kilodaltons. No XPA protein was detected in XP2OS
cells because of a G-C transversion in the splicing acceptor site in
intron 3 of the XPA gene. The asterisk indicates a nonspecific cross-
reacting band. (B) UV survival of repair-proficient MRC5 cells (),
clone 40 (), and XP2OS cells (‚) (see Materials and Methods). The
transfected cell line shows a wild-type correction of the XP-A-specific
UV sensitivity. (C) Phase-contrast image of a living clone 40 cell.
(D) Epifluorescence GFP image of the same cell as in panel C,
showing a homogeneous nuclear distribution. (E) Fluorescence im-
age after fixation of clone 40, showing a similar distribution as in
panel D. (F) Immunofluorescence of the same cell as in panel E incubated
with anti-XPA serum, showing a similar XPA distribution as with GFP
fluorescence, except for the nucleoli. (G) Expression profiles of XPA
(black bars) and GFP-XPA (gray bars) in MRC5 cells and clone 40,
respectively, after immunofluorescence staining with XPA antibodies.
GFP-XPA cells exhibiting an expression level similar to the major peak
of XPA expression in MRC5 cells were used in further experiments.
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covery was observed, as expected (Fig. 3A and B). In contrast,
in living cells the vast majority of GFP-XPA appeared to be
mobile (Fig. 3C and D). The kinetics of recovery yielded an
effective diffusion coefficient (Deff) for GFP-XPA of 15  2
m2/s. This Deff is much higher than that of XPB-GFP (6  1
m2/s), part of TFIIH, and we found it in repeated experi-
ments to be higher than that of ERCC1-GFP/XPF (12 2m2/s)
assayed in parallel. These data suggest that in undamaged cells
the majority (95%) of XPA is not incorporated into a stable
large complex and diffuses freely as single molecules (or part of
small transient subcomplexes) throughout the nucleoplasm.
DNA repair-dependent immobilization of GFP-XPA. To in-
vestigate the effect of the presence of DNA damage on XPA
mobility, we performed FRAP analysis on cells exposed to
UV-C (16 J/m2, an NER-saturating dose) (Fig. 3E and F). The
reduced fluorescence recovery, visible 2 s after bleaching (Fig.
3F [compare with nontreated cells shown in Fig. 3D]), and
the lower recovery of the diffusion plot (Fig. 3G) are indicative
for an immobilized fraction. The relative amount of binding
(maximally 35%) depends on the expression level, since cells
expressing high levels of GFP-XPA show a proportionally
smaller immobilized fraction compared with cells expressing
moderate amounts of GFP-XPA (Fig. 3G). This suggests that
at a given UV dose the total number of molecules participating
in the DNA repair reaction (i.e., immobilization) is roughly the
same in all cells independent of the expression level. The Deff
of the free fraction of GFP-XPA molecules did not change
after damage induction (13  2 m2/s) (Fig. 3G), indicating
that the free molecules were not incorporated into larger (mo-
bile) complexes.
To more precisely quantify the DNA damage-induced im-
mobilization of GFP-XPA, we used a different FRAP proce-
dure, FRAP-FIM, as described previously (29, 30). FRAP-FIM
measurements (the mean results for at least 30 cells) and
typical examples of cells are shown in Fig. 4. In accordance
with the strip-FRAP analysis, these measurements showed a
UV light-dependent (and maximally 35%) immobilization of
GFP-XPA (Fig. 4G to J). These results indicate that the num-
ber of immobilized molecules depends on the number of le-
sions. In addition, the total amount of immobilized molecules,
as shown above, does not depend on the amount of available
GFP-XPA molecules, suggesting that XPA is not the rate-
determining factor of NER in the cell line investigated. Note
that these experiments have been performed using SV40-im-
mortalized cells that have reduced levels of tp53, which causes
a decrease in GGR capacity (8).
The fraction of bound GFP-XPA molecules (35%) re-
mained more or less unaltered over a period of a few (2 to 4)
hours post-UV exposure. Subsequently, a gradual decrease of
immobilized molecules was observed, with no significant bind-
FIG. 3. Temporal FRAP analysis applied on GFP-XPA-expressing
cells to determine the immobile fraction after UV irradiation. Shown
are confocal images and corresponding FRAP profiles. The dotted line
indicates the position of the photobleaching strip. To determine a
potential immobile fraction, the mean intensity immediately before
bleaching was set as 1 and the fluorescence intensity immediately after
bleaching was set as 0. (A and B) Pre- and postbleach images, respec-
tively, of fixed cells, showing complete immobilization of GFP-XPA.
(C and D) Images of living cells monitored during FRAP, with panel
D showing a homogeneous bleaching throughout the nucleus 4 s after
the bleach pulse. (E and F) Images of living cells irradiated with 8-J/m2
UV-C. Note that the UV-irradiated cell (F) shows an intermediate
pattern between those of untreated (D) and fixed (B) cells. (G) Flu-
orescence recovery profile expressed as relative fluorescence plotted
against time after bleaching. Each plot is the mean value for at least 50
cells (fixed cells, untreated living cells, UV-irradiated cells expressing
relatively low levels of GFP-XPA, and UV-irradiated cells expressing
high levels of GFP-XPA). The immobile fraction can be calculated by
measuring the reduction of fluorescence recovery compared with non-
irradiated cells.
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ing 24 h after UV exposure (data not shown). Previous studies
have shown that 24 h after UV exposure most UV-induced
lesions have been removed by NER, suggesting full release of
bound molecules when repair is completed. This UV-induced
immobilization is specific for NER proteins, as previously re-
ported for ERCC1-GFP (29), and not observed in cells ex-
pressing single GFP or GFP-tagged RAD52 group proteins
(19). In summary, the above findings are consistent with the
idea that after DNA damage GFP-XPA molecules become
transiently immobilized by engagement in NER.
FIG. 4. FRAP-FIM method applied to GFP-XPA-expressing cells. Shown are confocal images and corresponding fluorescence ratio profiles
(FRP) of 50 cells. (A and B) Pre- and postbleach images, respectively, of cells fixed with 2% paraformaldehyde, displaying the immobilization of
GFP-XPA molecules after fixation, visualized by the intense bleached spot and high fluorescence intensity outside the bleached spot (B). (C) FRP
of fixed cells. (D and E) Images of living untreated cells, showing an overall reduction of fluorescence after the bleach pulse (E). (F) FRP of
untreated cells (green line). (G and H) Image of cells irradiated with 8-J/m2 UV-C. The UV-irradiated cell (H) displays a distribution pattern
intermediate of those of untreated (B) and fixed (E) cells. The “X” in panels A, D, and G represents the position of the bleach pulse. (I) FRP
of UV-irradiated cells (blue line). (J) Response of GFP-XPA immobilization to different UV doses.
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Local damage in GFP-XPA cells. To monitor the transloca-
tion of GFP-XPA molecules to damaged DNA in living cells
and to determine the transient binding (or residence) time
within NER complexes, we applied a novel technique for in-
troducing UV damage to a restricted area of the nucleus (43,
60). Cells were covered with a polycarbonate filter that shields
UV light and contains (5-m-diameter) pores (Fig. 5A), caus-
ing DNA damage after UV exposure only at the positions of
the pores. Shortly after UV irradiation (5 min, i.e., the first
time point analyzed), a clear accumulation of GFP-XPA mol-
ecules in restricted parts of the nuclei of living cells was ob-
served (Fig. 5C, arrows). These GFP-XPA accumulations co-
localize with XPC (Fig. 5D and E) and with CPDs (see Fig. 7D
and E) and confirm that XPA preferentially localizes to sites of
DNA damage (60). These observations suggest a model in
which (free) diffusing GFP-XPA molecules bind rapidly to
damaged DNA-NER complexes in which they were transiently
entrapped. To determine the residence time of GFP-XPA
within these locally damaged areas, we applied FLIP (see Ma-
terials and Methods). At a position opposite to the damaged
domain, a single pulse was used to bleach a small region in the
nucleus (Fig. 6B, inset). Both bleached and nonbleached mol-
ecules will distribute and mix, resulting in an overall decrease
in fluorescence intensity. The time required to establish the
initial (prebleach) fluorescence difference between the dam-
aged area and the nucleoplasm is a measure for the mean
residence time of molecules in that area. A typical series of
images of this FLIP measurement is shown in Fig. 6A. The
residence time for GFP-XPA was determined to be approxi-
mately 4 to 6 min (Fig. 6B). This residence time indicates the
average binding period (or time of participation) of GFP-XPA
molecules within a single NER event.
GFP-XPA mobility in an XPC-deficient background. To ob-
tain further evidence that immobilization is caused by actual
engagement in NER, we studied the dynamic properties of
GFP-XPA in a mutant NER background, i.e., an XPC-defi-
cient (XP20MA-SV) cell line. Using fluorescence-activated
cell sorting and immunoblot analyses (data not shown), a clone
FIG. 5. Accumulation of GFP-XPA within restricted nuclear areas after local UV irradiation. (A) Schematic presentation of local UV damage
infliction on living cultured cells. (B and C) Micrographs (phase-contrast image [B] and fluorescence image [C]) of living cells expressing GFP-XPA
(clone 40) and UV irradiated through a filter with small (5-m-diameter) pores. The arrows in panel C point to the local accumulations of
GFP-XPA. (D and E) GFP-XPA accumulations (arrows) shown in panel D clearly colocalize with endogenous XPC (E) concentrations, as
determined with anti-XPC antibodies, in fixed cells.
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was selected that expresses a relatively low level of GFP-XPA,
approximately a 1:1 ratio with endogenous nontagged XPA.
FRAP-FIM measurements revealed that even after a high
UV dose of 16 J/m2 no significant immobilization of GFP-XPA
was observed in XP-C cells (Fig. 7A and B). To study the
absence of immobilization in an XPC-deficient background in
more detail, local damage was applied to GFP-XPA-express-
ing, XPA- and XPC-deficient cells. GFP-XPA accumulates at
locally damaged areas (using CPD antibodies) (Fig. 7C to E)
only in the presence of XPC (Fig. 7, compare panels C to E
with panels F to H [absence of XPC]). These observations
clearly show that binding and transient immobilization of XPA
molecules to damaged regions depend on the presence of
functional XPC. Since XPC is only involved in GGR, these
results further suggest that with the applied FRAP methods
(and GFP-XPA), predominantly GGR is monitored, at least in
the analyzed time periods after UV exposure.
Loading of XPA and RPA in the NER preincision complex.
Our experiments indicated that incorporation of XPA into the
NER preincision complex depends on the presence of XPC
and that the XPA molecules get access to these lesions as a
free diffusing entity. These dynamic studies do not, however,
allow the determination of whether (part of the) XPA mole-
cules are complexed to other (small) nuclear factors, such as
RPA. It has been suggested that XPA is bound to the hetero-
trimeric RPA (26, 37, 39). Moreover, it has been claimed that
these proteins bind as a complex to DNA damage (61, 62). This
XPA-RPA complex has a higher and more lesion-discrimina-
tive binding capacity than each of the separate proteins (41).
To further investigate whether XPA gets access to the prein-
cision complex as a single protein or in conjunction with RPA,
we investigated the loading of RPA on UV lesions in a number
of different NER factor-deficient cells.
In agreement with previous findings for other NER proteins
(60), we found an accumulation of RPA in normal cells shortly
after the introduction of local UV damage in the cell (Fig. 8A
to C). The recruitment of XPA to the NER complex is not
impaired in XP-G/CS cells (60), despite the virtual absence of
XPG protein. Here we show that the relocalization of RPA to
locally induced UV damage is also not impaired in these cells
(Fig. 8D to F). This observation suggests that the recruitment
of XPA and RPA is independent of XPG or alternatively that
the XP-G/CS cells investigated might still express small
amounts of truncated XPG protein that are sufficient to sup-
port recruiting of XPA and RPA.
Surprisingly, however, when we tested cells lacking XPA we
also observed relocalization of RPA to the UV-damaged area
of the nucleus with an efficiency similar to that in wild-type
cells (Fig. 8G to I). This suggests that RPA is recruited to the
NER complex on the basis of its affinity for single-stranded
FIG. 6. Application of FLIP, using locally damaged cells, to determine the binding time of GFP-XPA molecules on damaged DNA. (A) Con-
focal images of a locally UV-damaged GFP-XPA-expressing cell (clone 40). Shown are images before application of a bleach pulse and at 20 s,
3 min, and 6 min after bleaching. (B) Fluorescence profile as a function of time; residence time was estimated to be 4 to 6 min, the time at which
the relative fluorescence difference between damaged area and background is established to be10% of the initial (prebleach) situation. The inset
shows the application of the FLIP procedure in local damaged cells: a laser beam is focused (between dotted lines) opposite to the damaged area
(arrow) (a typical example is shown in panel A).
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DNA, which is formed after the helix-unwinding action of
TFIIH, or that other (protein-protein) interactions than those
with XPA are sufficient to recruit RPA to the NER complex.
Support for the latter explanation comes from our observa-
tions with XP-B/CS cells, which have been reported to lack
helix opening in NER (20). In these cells, we could still observe
RPA accumulation in sites of local UV damage (Fig. 8J to L).
The same result was obtained with an XP-D/CS cell line bear-
ing a mutation in the other helicase subunit, XPD of TFIIH
(data not shown).
These findings are in accordance with recent observations by
Patrick and Turchi (47), who presented evidence that initial
binding of RPA to the damaged DNA is subsequently further
stabilized by an interaction with XPA. Whether XPA is incor-
porated in the NER complex in vivo in the absence of RPA
remains to be determined.
Furthermore, it has been suggested by Wakasugi and co-
workers that the DDB protein complex might be responsible
for the direct recruitment of XPA and RPA to sites of damage,
without the need for the XPC/hHR23B complex (62). How-
ever, when we investigated XPC-deficient cells (that contain
normal functional DDB complex) we found no accumulation
of RPA in sites of local UV damage (Fig. 8M and N), in
accordance with our previous findings that no NER proteins,
including XPA, were found at sites of locally induced UV
damage in XP-C cells. This observation together with our
group’s present and previous observations (60) support the
notion that the visible assembly of the NER complex on a
FIG. 7. Effect of XPC on damage-induced XPA immobility as analyzed by FRAP-FIM and local damage induction. (A) FRAP-FIM profile of
GFP-XPA expression in XP20MA (XP-C) cells. Shown are results for nonirradiated cells (light green line), cells irradiated at 16 J/m2 (blue line),
and fixed cells (black line). UV-exposed XP20MA cells do not show any GFP-XPA immobilization. (B) Quantification of immobilization of
GFP-XPA in XP20MA and XP2OS cells with and without UV irradiation. (C) Phase-contrast image of GFP-XPA-expressing XP2OS cells.
(D) Anti-CPD immunostaining in a GFP-XPA-expressing XP2OS cell. The arrow indicates the site of the damage. (E) GFP image of the same
cell as in panel D, showing enrichment of GFP-XPA at the damaged site. (F) Phase-contrast image of GFP-XPA-expressing XP20MA cells.
(G) Anti-CPD immunostaining of a GFP-XPA-expressing XP20MA cell, indicated by the arrow. (H) GFP image showing no enrichment of
GFP-XPA molecules.
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DNA lesion strictly depends on functional XPC protein, and
we have found no evidence for direct recruitment of XPA
and/or RPA by the DDB protein. Importantly, our observa-
tions are in contrast with the new order of assembly recently
suggested by Reardon and Sancar (48), who describe a model
in which RPA loading precedes XPC.
DISCUSSION
The XPA protein plays an essential role in mammalian NER
that until now has largely been assessed using biochemical and
genetic means. In this study, we applied different variants of
FRAP (30) on living cells stably expressing (at a biologically
relevant level) functional GFP-XPA. These analyses provide
insight into the hitherto unexplored in vivo spatiotemporal
organization of this central NER factor.
The following observations indicate that the GFP-XPA-ex-
pressing cells accurately reflect the in vivo involvement of XPA
in NER. (i) Expression in XPA-deficient cells established that
the GFP-XPA protein is fully functional in NER in terms of
UV survival and repair synthesis, despite the presence of the
GFP tag, almost doubling the size of the protein. (ii) GFP-
XPA is expressed at physiological levels, which is critical when
analyzing the biologically active fraction of the protein. (iii)
The subnuclear distribution is similar to that of wild-type,
endogenous XPA (Fig. 1 and 2). (iv) As discussed below, the
protein shows a consistent, direct, and specific response to
NER-type DNA injury. Therefore, we consider this cell line to
be a bona fide tool for studying the characteristics of XPA in
living cells.
Organization of NER in living cells. Diffusion measure-
ments in living cells indicated that the majority of GFP-XPA
FIG. 8. Relocalization of RPA to the NER complex 30 min after local irradiation with 25-J/m2 UV. (A to C) Anti-XPC (A) and anti-RPA
(B) immunostaining of VH25 cells and the merged image after immunostainings plus DAPI nuclear DNA staining (C). (D to F) Anti-XPA (D) and
anti-RPA (E) immunostaining of XPCS1RO cells and the merged image after immunostainings plus DAPI nuclear DNA staining (F). (G to I)
Anti-XPC (G) and anti-RPA (H) immunostaining of XP25RO cells and the merged image after immunostainings plus DAPI nuclear DNA staining. (J to
L) Anti-XPC (J) and anti-RPA (K) staining of XP131MA cells and the merged image after immunostainings plus DAPI nuclear DNA staining (L).
(M and N) Anti-RPA immunostaining of XP21RO cells (M) and the merged image after immunostaining plus DAPI nuclear DNA staining (N).
The yellow color in the merged images in panels C, F, I, and L indicates colocalization of NER proteins at sites of locally induced DNA damages.
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molecules are not part of a large, stable, preassembled NER
complex. Obviously, we cannot exclude the possibility that a
small fraction of XPA is incorporated into a larger functional
NER (holo)complex. However, it is hard to envisage that such
a small amount would be sufficient to account for the observed
biological activity that involves a substantial fraction (30%)
of the XPA proteins actually participating in NER (Fig. 4).
The absence of (significant quantities of) preassembled NER
holocomplexes containing XPA (as determined here) in living
cells contrasts with the results of an earlier biochemical study
of Saccharomyces cerevisiae in which a completely assembled
NER complex was identified (54). It is, however, not excluded
that part of the XPA molecules are present in smaller (tran-
sient) complexes, as reported previously (3, 16, 23, 61). Several
explanations may account for these differences. First, during
cell lysis and extract preparation, ionic-strength and local con-
centrations are different from those in the in vivo situation. In
addition, competing factors, or natural substrates, such as
DNA and/or chromatin, are absent. This will affect (and may
even enhance) associations between proteins with an intrinsic
affinity for each other, influencing copurification and immuno-
precipitation behavior. Second, many reported interactions be-
tween NER factors are based on two-hybrid screens or immo-
bilized factors on column matrices (reviewed in references 5
and 15). In both of these cases, high local concentrations of
one NER factor will artificially shift the association-dissocia-
tion equilibrium to the side of binding. Finally, the process of
an ordered repair complex assembly in mammalian nuclei (60)
might differ from the situation in yeast cells due to differences
in genome size and nuclear structure.
Transient immobilization of GFP-XPA in DNA repair. Here
we provide evidence that GFP-XPA immobilization is linked
to actual repair and involves sequential NER complex assem-
bly on DNA lesions in living cells. Immobilization of GFP-
XPA is likely due to either direct sequestration to damaged
DNA or entrapment into NER reaction intermediates. First,
free diffusing GFP-XPA became partially immobilized when
DNA damage was inflicted by UV light. Our in vivo results are
consistent with the previously reported binding of XPA to
nuclear structures after UV irradiation as determined by re-
duced Triton X-100 extractability on fixed cells (55). Second,
the UV-induced immobilization is found specifically for NER
factors and is not noted with other proteins, such as transcrip-
tion activators and proteins implicated in other repair path-
ways (19, 29). Third, the fraction of immobilized GFP-XPA
appears to depend on the number of lesions induced by UV
irradiation. Fourth, we observed a time-dependent reduction
of the amount of trapped GFP-XPA after UV irradiation, with
no significant binding 24 h post-UV exposure. This is in agree-
ment with the notion that when DNA repair proceeds, fewer
target sites are available for binding GFP-XPA. Fifth, as dis-
cussed below, XPA immobilization does not occur in an XPC-
deficient background. Finally, we visualized a fast recruitment
of GFP-XPA to areas of local UV damage in nuclei of living
cells. FLIP measurements indicated that GFP-XPA molecules
reside for approximately 4 to 6 min within these locally dam-
aged sites.
The transient UV dose-dependent immobilization of GFP-
tagged ERCC1 in CHO cells and that of GFP-XPA analyzed
here in human cells show comparable kinetics in terms of the
maximum fraction of molecules that become immobilized and
the UV dose at which both reach a plateau. The rate at which
both proteins accumulate in damaged regions of nuclei (data
not shown) and their residence time at these areas are quite
similar as well. The observed comparable reaction kinetics, on
rate, binding time, and substrate (UV damage) dependency
suggest that both factors enter the NER complex, stay bound,
and are subsequently released from the DNA lesion-NER
complex at about the same time. A marked difference, how-
ever, is that in the CHO cell line expressing ERCC1-GFP the
total repair time (i.e., time after UV irradiation where no
notable immobilization of ERCC1-GFP is observed anymore)
is significantly shorter than in the case of GFP-XPA. This
difference is likely due to the virtual absence of CPD removal
of nontranscribed DNA (GGR) in rodent cells, in contrast to
the more complete repair of CPDs in human cells (31).
Order of NER factor assembly. Both UV-dependent immo-
bilization (Fig. 7A and B) and accumulation of GFP-XPA at
nuclei with local UV damage depend on the presence of XPC
(Fig. 7C to H). These findings provide in vivo evidence sup-
porting the results of previous biochemical studies indicating
that the action of XPC/hHR23B precedes the XPA involve-
ment in NER (6, 52, 53, 64). They are also in line with previous
immunocytochemistry analysis results (60) indicating that as-
sembly of various NER factors (XPA, TFIIH, ERCC1/XPF,
and XPG) at a local damaged area is dependent on XPC.
The major (and perhaps only) difference between TCR and
GGR is based on the (initial) recognition step. It is therefore
also likely that the factors that are different in the two path-
ways, i.e., XPC/hHR23B (and for some lesions UV-DDB [or
XPE]) (56) and the CS factors, respectively, for GGR and
TCR, are the respective damage sensors for both NER sub-
pathways. In addition, XP group A cells are deficient in both
GGR and TCR, whereas XP-C and CS cells are selectively
defective in GGR and TCR, respectively, which argues against
an initial damage-sensing role for XPA. Since XPC only ac-
counts for GGR, it is surprising that in XP-C cells, no local
accumulation of GFP-XPA was observed, whereas these cells
have a normal functional TCR. Apparently, the contribution of
TCR in these cells is too low to be detected by the currently
applied immunocytochemistry procedure using local irradia-
tion or FRAP-FIM techniques.
Surprisingly, we also found that RPA is localized to UV-
damaged subnuclear regions in the absence of XPA, suggesting
that at least for the loading of RPA into the NER preincision
complex, association to XPA is not required. In addition to the
observed diffusion rates of GFP-XPA, it is therefore conceiv-
able that the majority of XPA and RPA are not complexed
prior to binding to the NER lesion. In view of the multiple
roles of RPA, it is also plausible that association of RPA to its
interacting partners, here XPA, only occurs after entrance to
the specific site of action.
Furthermore, local accumulation of RPA to UV-damaged
areas seemed to depend on functional XPC, whereas XPA and
XPG appeared to be dispensable for this relocalization. How-
ever, it cannot be excluded that the severely truncated XPG
protein present in XP-G/CS cells is sufficient to (make it pos-
sible to) recruit RPA to the NER complex. A further point of
interest is the observation that the functionality of the helicase
subunits of TFIIH (XPB and XPD), which cause the formation
VOL. 23, 2003 XPA IN LIVING CELLS 5765
of a single-stranded DNA region around the lesion that could
theoretically attract RPA to the site of NER, is in fact dispens-
able for this recruitment. Our results therefore indicate that
RPA is also not incorporated into the forming NER complex
on the basis of its affinity for this single-stranded DNA region
only but may require protein-protein interactions of early NER
factors. These findings raise the question as to what causes the
entry of RPA into the NER complex, i.e., which protein(s) or
protein function(s) is necessary and indispensable for RPA to
be recruited to the NER complex, and the timing of this entry.
Theoretically, given our findings, it is possible that RPA enters
the NER complex as the third protein (complex), after XPC/
hHR23B/centrin 2 and TFIIH, in order to be incorporated into
the NER incision complex. At present, however, we cannot
exclude the possibility that the XPG protein precedes this step.
Advantages of a sequential assembly model for NER. This
work combined with our group’s previous study (29) shows that
repair factors XPA and ERCC1/XPF participate in NER by a
temporary entrapment of free diffusing proteins into NER-
DNA lesion complexes. These results favor an “assembly on
the spot” model for individual NER factors rather than a mod-
el of preassembled NER complexes. Preassembled “repairo-
somes” might be considered to be efficient “machines” ready to
act on demand. On the other hand, dynamic assembly and
disassembly of molecular complexes allows a more combina-
torial flexibility of the reaction constituents that participate in
other mechanisms. This is particularly relevant for NER, since
almost all NER factors, except XPA, are known to participate
also in other DNA-metabolizing processes. TFIIH and CSB
are involved in transcription (50, 58), ERCC1/XPF functions
also in recombination repair (46), XPG plays an additional
role in base excision repair (BER) (12, 36), and the single-
stranded DNA binding protein hRPA acts in almost every
DNA transaction. The latter is perhaps the prototype of a
multilateral factor, since this hRPA functions in at least repli-
cation, NER, BER, and homologous recombination (34, 40).
The different repair proteins (from BER, NER, and double-
strand break repair) interact with a common small domain of
this protein, arguing for a competitive association with RPA,
rather than divers preassembled subcomplexes including RPA
specific for each cellular function. A distributive, diffusion-
driven model has the advantage of permitting efficient usage
and quick switching of proteins or protein complexes between
distinct nuclear processes. An additional important advantage
of sequential assembly of NER factors is that it allows regula-
tion at multiple levels.
The involvement of many NER factors in other processes
may imply that the basic rules learned here for NER are also
applicable to those other systems, at least when shared NER
factors are concerned. Nuclear processes, such as replication
and transcription, are scheduled and confined or initiated at
specific loci in the genome. These mechanisms may require
structural nuclear elements that coordinate their specific spa-
tial and temporal actions. High local concentrations of specific
factors have indeed been found, and models have been put
forward in which DNA is pulled through these “factories” (11).
However, such a spatiotemporal regulation might be less ben-
eficial for repair than for replication and transcription, since
repair has to act at any location in the genome at any moment
in the cell cycle. Free diffusion of repair factors and binding
when affinity is increased by a structural change (lesion) seems
to be more efficient than tracking along relatively crowded
DNA stretches or chromatin fibers by large complexes over
long distances before they encounter injuries. However, a par-
tial scanning mode of action is not excluded for all NER
factors. Lesion detection within TCR is by definition per-
formed by a DNA-tracking RNA polymerase II elongation
complex. A similar scenario for the initial step in GGR can be
envisaged.
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